table of content
1 Introduction to Research & Analysis Reports
1.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Overall Market Size
2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size: 2022 VS 2029
2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales: 2018-2029
3 Company Landscape
3.1 Top Non-alcoholic Steatohepatitis (NASH) Biomarkers Players in Global Market
3.2 Top Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Companies Ranked by Revenue
3.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Companies
3.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Companies
3.5 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-alcoholic Steatohepatitis (NASH) Biomarkers Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Players in Global Market
3.8.1 List of Global Tier 1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size Markets, 2022 & 2029
4.1.2 Serum Biomarkers
4.1.3 Cytokeratin-18 (CK 18) Marker
4.1.4 Inflammatory Markers
4.1.5 Others
4.2 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2023
4.2.2 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2024-2029
4.2.3 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
4.3 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales & Forecasts
4.3.1 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2023
4.3.2 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2024-2029
4.3.3 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
4.4 By Type - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Diagnostic Centers
5.1.4 Others
5.2 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2023
5.2.2 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2024-2029
5.2.3 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
5.3 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales & Forecasts
5.3.1 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2023
5.3.2 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2024-2029
5.3.3 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
5.4 By Application - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2022 & 2029
6.2 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2023
6.2.2 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2024-2029
6.2.3 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share, 2018-2029
6.3 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales & Forecasts
6.3.1 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2023
6.3.2 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2024-2029
6.3.3 By Region - Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2029
6.4.2 By Country - North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2029
6.4.3 US Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.4.4 Canada Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.4.5 Mexico Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2029
6.5.2 By Country - Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2029
6.5.3 Germany Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.4 France Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.5 U.K. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.6 Italy Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.7 Russia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.8 Nordic Countries Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.5.9 Benelux Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2029
6.6.2 By Region - Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2029
6.6.3 China Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.6.4 Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.6.5 South Korea Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.6.6 Southeast Asia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.6.7 India Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2029
6.7.2 By Country - South America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2029
6.7.3 Brazil Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.7.4 Argentina Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, 2018-2029
6.8.3 Turkey Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.8.4 Israel Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.8.5 Saudi Arabia Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
6.8.6 UAE Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Biopredictive
7.1.1 Biopredictive Company Summary
7.1.2 Biopredictive Business Overview
7.1.3 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.1.4 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.1.5 Biopredictive Key News & Latest Developments
7.2 Quest Diagnostics
7.2.1 Quest Diagnostics Company Summary
7.2.2 Quest Diagnostics Business Overview
7.2.3 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.2.4 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.2.5 Quest Diagnostics Key News & Latest Developments
7.3 Exalenz Bioscience
7.3.1 Exalenz Bioscience Company Summary
7.3.2 Exalenz Bioscience Business Overview
7.3.3 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.3.4 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.3.5 Exalenz Bioscience Key News & Latest Developments
7.4 GENFIT
7.4.1 GENFIT Company Summary
7.4.2 GENFIT Business Overview
7.4.3 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.4.4 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.4.5 GENFIT Key News & Latest Developments
7.5 Siemens Healthineers
7.5.1 Siemens Healthineers Company Summary
7.5.2 Siemens Healthineers Business Overview
7.5.3 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.5.4 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.5.5 Siemens Healthineers Key News & Latest Developments
7.6 ONE WAY LIVER
7.6.1 ONE WAY LIVER Company Summary
7.6.2 ONE WAY LIVER Business Overview
7.6.3 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.6.4 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.6.5 ONE WAY LIVER Key News & Latest Developments
7.7 Prometheus Laboratories
7.7.1 Prometheus Laboratories Company Summary
7.7.2 Prometheus Laboratories Business Overview
7.7.3 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.7.4 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.7.5 Prometheus Laboratories Key News & Latest Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Major Product Offerings
7.8.4 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Revenue in Global (2018-2023)
7.8.5 Gilead Sciences Key News & Latest Developments
8 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Capacity, Analysis
8.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Capacity, 2018-2029
8.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-alcoholic Steatohepatitis (NASH) Biomarkers Supply Chain Analysis
10.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Value Chain
10.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Upstream Market
10.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
